Versant Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.5K | Sell |
999
-126
| -11% | -$3.97K | ﹤0.01% | 1247 |
|
|
2025
Q1 | $36.8K | Buy |
1,125
+1,109
| +6,931% | +$36.3K | 0.01% | 1001 |
|
|
2024
Q4 | $579 | Hold |
16
| – | – | ﹤0.01% | 2260 |
|
|
2024
Q3 | $499 | Hold |
16
| – | – | ﹤0.01% | 1867 |
|
|
2024
Q2 | $428 | Hold |
16
| – | – | ﹤0.01% | 1815 |
|
|
2024
Q1 | $546 | Hold |
16
| – | – | ﹤0.01% | 1675 |
|
|
2023
Q4 | $463 | Buy |
+16
| New | +$463 | ﹤0.01% | 1701 |
|
|
2023
Q3 | – | Sell |
-19
| Closed | -$571 | – | 2052 |
|
|
2023
Q2 | $571 | Buy |
+19
| New | +$571 | ﹤0.01% | 1802 |
|
|
2021
Q2 | – | Sell |
-559
| Closed | -$15K | – | 1586 |
|
|
2021
Q1 | $15K | Sell |
559
-185
| -25% | -$4.96K | 0.01% | 655 |
|
|
2020
Q4 | $18K | Sell |
744
-24
| -3% | -$581 | 0.01% | 547 |
|
|
2020
Q3 | $16K | Hold |
768
| – | – | 0.01% | 506 |
|
|
2020
Q2 | $18K | Buy |
768
+192
| +33% | +$4.5K | 0.01% | 459 |
|
|
2020
Q1 | $10K | Buy |
+576
| New | +$10K | 0.01% | 562 |
|
|
2019
Q4 | – | Sell |
-26
| Closed | – | – | 1565 |
|
|
2019
Q3 | $0 | Buy |
+26
| New | – | ﹤0.01% | 1575 |
|